Related Experiment Video
Updated: Jun 3, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Myeloproliferative/myelodysplastic syndromes]
Eric Solary1, Michaëla Fontenay
1Inserm UMR1009, Institut Gustave-Roussy, université Paris-Sud, 94805 Villejuif. eric.solary@igr.fr
La Revue Du Praticien
|March 24, 2011
Summary
Myeloproliferative/myelodysplastic syndromes, like chronic myelomonocytic leukemia, involve abnormal cell growth and low blood counts. Genetic mutations are key to understanding these rare, aggressive blood cancers.
Area of Science:
- Hematology
- Oncology
- Genetics
Context:
- Myeloproliferative/myelodysplastic syndromes (MPN/MDS) are rare blood disorders.
- Chronic myelomonocytic leukemia (CMML) is the most common MPN/MDS, primarily affecting the elderly.
- CMML exhibits both proliferative and dysplastic features, leading to cytopenias.
Purpose:
- To explore the genetic landscape of CMML.
- To understand the pathogenesis of MPN/MDS.
- To inform risk-stratified patient care and treatment strategies.
Summary:
- Frequent mutations in TET2, ASXL1, and RUNX1 are identified in CMML.
- Less frequent mutations include NRAS, KRAS, and C-CBL; rare mutations involve JAK2, FLT3, IDH1/2, and EZH2.
- Patient management hinges on risk assessment (blast percentage, age, performance status).
- Allogeneic stem cell transplantation is curative but often infeasible.
- Demethylating agents (azacitidine, decitabine) are current mainstays.
- Prognosis remains poor, with median survival under 24 months.
Impact:
- Advances in understanding CMML pathogenesis through genetic mutation identification.
- Highlights the challenges in treating elderly patients with MPN/MDS.
- Emphasizes the limited efficacy of current treatments and the poor prognosis for CMML patients.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...